A 24 year old woman in the 33rd week of pregnancy developed progressive neurological complications with right sided hemiparesis in association with the occurrence of linear scleroderma “en coup de sabre” (LSCS) and pre-existing plaque-morphea, already being treated by balneophototherapy. Further progression of neurological symptoms led to a caesarean section with the delivery of a healthy child. Brain magnetic resonance imaging (MRI) showed focal T2 signal increases in the left frontoparietal region directly adjacent to the area of LSCS. Cerebrospinal fluid analysis revealed oligoclonal bands, suggesting an intracerebral inflammatory process. Subsequent pulsed corticosteroid treatment led to a remission of neurological symptoms and to a marked resolution of the MRI lesions.
- linear scleroderma “en coup de sabre”
- central nervous system nflammation
Statistics from Altmetric.com
Linear scleroderma “en coup de sabre” (LSCS) and plaque-morphea are both variants of localised scleroderma.1 LSCS presents as band-like sclerotic skin lesions, usually involving a single unilateral change in the frontoparietal area of the head. This is characterised by atrophy and a furrow of the skin. Progressive involution of the craniofacial bones may result in hemifacial atrophy, which appears to be identical to the Parry Romberg syndrome (idiopathic progressive facial hemiatrophy). A clear differentiation between Parry Romberg syndrome and LSCS is often not possible and the aetiology of the two conditions may be similar.2
Plaque-morphea is characterised by circumscribed sclerotic plaques with ivory coloured centres and, in the active state of the disease, with violaceous borders. With further progression the centre becomes white or yellowed. Most commonly the lesions are single or few in number, but they may be multiple and are typically localised on the trunk and the extremities.
Compared with plaque-morphea, LSCS may be accompanied by neurological complications such as epileptic seizures and other focal neurological symptoms.2–7 Ipsilateral abnormalities of brain imaging have been reported in patients with LSCS.2,4,5,7–9
We report an unusual case of a pregnant woman with pre-existing plaque-morphea, newly developed LSCS associated with progressive neurological symptoms, and a rapid response to pulsed corticosteroid treatment.
A 24 year old woman presented with a two week history of slowly progressive weakness and fine motor disturbances in her right arm. At the age of 20 a plaque-morphea was diagnosed clinically (fig 1, panels B and D) and the patient was treated with several courses of balneophototherapy, leading to partial remission of the lesions. There was no progression of skin lesions or any neurological abnormalities during follow up.
On admission the patient was in the 33rd week of pregnancy. She was fully oriented, had normal speech, and presented with a right sided hemiparesis (grade 3/5, MRC scale) with a positive Babinski sign on the right. There was no history of head trauma.
Routine laboratory testing and comprehensive serological screening including antineutrophilic cytoplasmic antibodies (ANCA), anticardiolipin antibodies, and antibodies against Borrelia burgdorferi, was unremarkable except for a mildly increased antinuclear antibody titre (1:160, with a homogeneous pattern). CSF analysis showed a normal cell count (7 leucocytes/mm3) and normal protein and glucose, but electrophoresis revealed intrathecal production of IgG and IgM with oligoclonal bands.
Magnetic resonance imaging (MRI) showed multiple lesions with high signal intensity on T2 weighted images in the left hemisphere, accentuated over the frontoparietal region and involving the white matter with some small hyperintensive subcortical foci over the right frontal regions (fig 2). No significant brain atrophy was found. MRI was done without gadolinium enhanced T1 weighted images because of the pregnancy.
Rapid progression of neurological symptoms prompted a caesarean section with delivery of a healthy child. Further dermatological examination revealed a linear sclerotic atrophic area with hypo- and hyperpigmentation of the left forehead (fig 1, panels A and C), compatible with LSCS, which was confirmed by the typical histopathology on skin biopsy, with fibrosis and sclerosis in the deep regions of the dermis. There was no sign of systemic sclerosis.
Cerebral computed tomography (CCT) done after delivery showed parenchymal calcifications (fig 3) in the left frontoparietal regions and skull atrophy directly under the cutaneous lesion. The patient was treated with a pulsed intravenous corticosteroid (methylprednisolone) regimen, 1 g daily for three days followed by 500 mg daily for further three days, and a consecutive tapering period with oral methylprednisolone. During the following two weeks this treatment led to a rapid improvement in the neurological symptoms with the paresis resolving completely, though the positive Babinski sign remained. Repeat MRI 14 days later showed gadolinium enhanced white matter lesions over the left frontoparietal regions on T1 weighted images, but the lesions showed marked resolution (fig 4). Because of the rapid clinical improvement we did not undertake a brain biopsy. The patient recovered well and was discharged five weeks after the onset of her neurological symptoms.
Central nervous system involvement in patients with LSCS has been described in several case reports. Patients may present with epileptic seizures2–4,7,8 and other focal neurological symptoms.2,4,5,11 Neuroradiological abnormalities, including cerebral atrophy, white matter lesions, parenchymal calcification, meningeocortical alterations, and skull atrophy, have been described in patients with LSCS.2,4,5,8–12
Our patient developed progressive right sided hemiparesis during pregnancy. The initial MRI (fig 2) showed multiple white matter lesions over the left frontoparietal regions adjacent to the LSCS, and some small hyperintense subcortical foci over the right frontal regions. Repeat MRI (fig 4), done after a pulsed corticosteroid treatment, showed marked resolution of the lesions. Computed tomography (fig 3) revealed parenchymal calcification in the corresponding area and mild skull atrophy under the skin lesion.
Neuropathological findings in patients with LSCS2,7 provide evidence for an underlying inflammatory process rather than a vascular dysgenetic origin4 as a causative pathogenic pathway. The occurrence of oligoclonal bands in the cerebrospinal fluid, the lesions on MRI, and the response to immunosuppression provide further evidence for this hypothesis.2,5. The MRI findings, the intrathecal production of immunoglobulins, and the excellent response to corticosteroid treatment in our patient support this hypothesis.
Histologically, the skin lesions show perivascular lymphocytic infiltration, proliferation of fibroblasts, and dense collagen deposition within the dermis, and—in contrast to plaque-morphea—the deeper connective tissues including muscle and bone structures may be involved in LSCS. The involvement of all structures including the brain underlying LSCS lesions in our patient is intriguing and suggests an ongoing inflammatory process.
To our knowledge there is only one case report describing LSCS in association with plaque-morphea and neurological complications. Menni and coworkers10 described two children with both sclerotic and atrophic skin lesions on half of the face and coexisting plaque-morphea, who developed neurological and radiological manifestations years after the onset of the dermatological symptoms. The neurological symptoms resolved spontaneously.
The exacerbation of the disease during pregnancy in our patient deserves further comment. The influence of pregnancy on the course of autoimmune diseases is well documented, in particular in patients with systemic lupus erythematosus.16 The pathogenesis of both plaque-morphea and LSCS is still unknown; however, autoimmune mechanisms are suspected, leading to the fibrotic changes in skin tissues.17,18 We therefore speculate that in our patient pregnancy related hormonal changes could have induced further progression of the disease, with the development of LSCS and cerebral involvement.
Competing interests: none declared
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.